According to Sigilon Therapeutics's latest financial reports the company's current revenue (TTM ) is โฌ15 Million. In 2022 the company made a revenue of โฌ12.06 Million an increase over the revenue in the year 2021 that were of โฌ8.47 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.